Physician profile

David Wiener

Orthopaedic Surgery · Toms River, NJ

NPI 1417084468

$4,404.15

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$272.98

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Stryker Corporation $3,435.03 2019-2023 Mako
Zimmer Biomet Holdings, INC. $316.51 2021
Nuvasive, INC. $227.76 2020
Linkbio Corp $177.48 2021
Smith+Nephew, INC. $138.50 2019
Baxter Healthcare $33.54 2024 Floseal
Si-Bone, INC. $30.66 2024
Depuy Synthes Sales INC. $29.53 2023 Na
Kowa Pharmaceuticals America, INC. $15.14 2023 Seglentis

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

David Wiener

$4,404.15

in general payments reported 2019-2025

Years
2019-2024
Top company
Stryker Corporation

https://glasscript.com/doctor/517395/david-wiener

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.